Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment

Inactive Publication Date: 2011-09-22
INSTITUT GUSTAVE ROUSSY +2
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0018]The present invention also concerns a method for increasing the efficacy of a chemotherapeutic or radiotherapeutic treatment in a subject suffering from a cancer and having a non-functional P2X7-elicited NALP3 inflammasome pathway, wherein

Problems solved by technology

However, one of the most important problems in cancer treatment remains that individual subjects with the same histology do not respond identically to a given agent or a given therapeutic protocol.
However, radiotherapy and some chemotherapeutic agents could also induce specific immune responses resulting in immunogenic cancer cell death or in immunost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment
  • Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment
  • Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment

Examples

Experimental program
Comparison scheme
Effect test

examples

[0173]Material and Methods

[0174]Mouse Strains

[0175]BALB / c (H-2d), C57BL / 6 (H-2b), nu / nu and Rag2− / − C57BL / 6 mice were obtained from the Centre d'élevage Janvier (Le Genest St Isle, France) and from Charles River Laboratories (L'Arbresle, France), as well as from Taconic (Denmark).

[0176]C57BL / 6 Ifnγr1− / −, Casp1− / −, Asc− / −, Nalp3− / −, P2X7− / −and IL-12Rβ2− / − mice were described in Huang et al, 1993; Li et al., 1995; Srinivasula et al., 2002; Kanneganti et al., 2006; Solle et al., 2001; and Wu et al., 2000, respectively. Mice were bred in pathogen-free conditions. Animals were used between 6 and 20 weeks of age. All animals were maintained according to both the FELASA guidelines and the Animal Experimental Ethics Committee Guidelines (Val de Marne, France).

[0177]Reagents and Materials

[0178]Cell death was induced either with doxorubicin, mitoxantrone (Sigma Aldrich, St Quentin Fallavier, France), or oxaliplatin (Sanofi-Aventis, France). Ovalbumin protein was purchased

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Cell deathaaaaaaaaaa
Electrical resistanceaaaaaaaaaa
Cell angleaaaaaaaaaa
Login to view more

Abstract

The present invention concerns methods for assessing the sensibility of a subject to an anticancer treatment, for screening compounds which are useful for treating a cancer and for determining the likelihood of a metastatic relapse in a subject. The methods are based on the finding that a non-functional P2X7-elicited NALP3 inflammasome pathway in a subject is indicative of a resistance to treatment. The invention further concerns methods for treating a cancer and for restoring the sensitivity of the subject to a cancer treatment.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner INSTITUT GUSTAVE ROUSSY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products